TrialClinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases2023

Evaluating the efficacy and safety of SpikoGen®, an Advax-CpG55.2-adjuvanted severe acute respiratory syndrome coronavirus 2 spike protein vaccine: a phase 3 randomized placebo-controlled trial.

Payam Tabarsi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.